The firm acknowledges that Sunoco faces downside risks, which could stem from a negative shift in commodity market conditions or the economics of potential future projects and mergers and acquisitions ...

RBC Capital analyst Nelson Ng maintained a Hold rating on Methanex (MEOH – Research Report) on January 27 and set a price target of $55.00. The ...

RBC Capital analyst Brad Heffern maintained a Hold rating on UDR (UDR – Research Report) today and set a price target of $43.00. The company’s ...

RBC Capital Markets advised on a total of 34 deals ... Evercore was third with 19, Barclays came fourth with 18 and Goldman Sachs secured fifth spot with 16 deals. GlobalData’s league tables ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...

But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and perhaps even better with the right stock investments. "The overall ...

Victory Capital (NASDAQ:VCTR – Free Report) had its target price upped by Barclays from $69.00 to $70.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight ...

"Prices have moved up nearly 16% since Thursday with no 'normal' reasons that could justify this price action," Tyler Broda, an RBC Capital Markets analyst, said in a February 1 research note.

On Thursday, RBC Capital Markets adjusted their stance on Neumora Therapeutics (NASDAQ:NMRA), downgrading the stock from an Outperform to a Sector Perform rating. This change comes in the wake of ...